Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas

通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤

基本信息

  • 批准号:
    10987699
  • 负责人:
  • 金额:
    $ 8.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-06 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Deborah Stephens, DO is an Assistant Professor (to be Associate in July 2022) at the Huntsman Cancer Institute (HCI) who focuses on clinical investigation for patients with chronic lymphocytic leukemia (CLL) and B- cell lymphoma, the most common adult blood cancers. Despite recent advances in the field, CLL and relapsed/refractory B-cell lymphomas are mostly considered incurable. Resistance to therapy is common resulting in poor clinical outcomes. Dr. Stephens’s research is focused on CLL and lymphoma patient care and survival through development and management of a clinical trial portfolio at HCI that includes National Cancer Institute (NCI)-sponsored investigator-initiated trials. The scope of this program is significant, improves the care of local patients and has produced has changed the standard of care for patients internationally. Through several national and local leadership roles, Dr. Stephens dedicates 40% of her time to performing and promoting NCI-sponsored clinical trials. This work, currently not funded, would be supported by the R50 Research Scientist award and support the continuation and development of Dr. Stephens’s work. She is the CLL Lead for the SWOG Leukemia Working Group, which encompasses her roles as the national principal investigator (PI) for the S1925 EVOLVE CLL trial (NCT04269902) and leader of a task force to develop the next SWOG trial for CLL patients. Through the SWOG Lymphoma Working Group, Dr. Stephens has analyzed and published (as first author) the long-term follow-up of several pivotal lymphoma studies. She serves as the local PI for numerous NCI-sponsored CLL and lymphoma studies, which has resulting in placing HCI among leaders in national accrual in several studies including S1925, EA9161, and A041702 (CLL) and EA4151 and EA4181 (mantle cell lymphoma). At HCI, she serves on several committees dedicated to hematology clinical research, including HCI Hematology Disease Center (Interim Director), Hematology Clinical Trials Research Group (Physician Leader), Independent Protocol Review Committee (member), and the Center for Investigational Therapeutics (member). Building upon connections from her fellowship and extensive clinical trial collaboration with investigators at The Ohio State University (OSU), she developed a partnership with OSU and the University of Kentucky that enabled HCI’s successful UM1 ETCTN program application and resulted in grant 60075822 (Carson). She serves as the Hematology Expert for HCI on the ETCTN Executive Committee. The R50 Grant, would support Dr. Stephens to continue her work and plans for meeting the objectives of the NCI-funded clinical trials research program by (1) translation of HCI research into NCI-sponsored clinical trials and expand collaborative grant opportunities through advocating for targeted recruitment of key collaborating scientists, (2) expanding access to phase 1/2 clinical trials to all patients in HCI’s catchment areas, and (3) increasing the number of under-represented minorities and women through collaborations with HCI’s Community Outreach and Education and Patient Navigation Programs.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORAH STEPHENS其他文献

DEBORAH STEPHENS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORAH STEPHENS', 18)}}的其他基金

Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
  • 批准号:
    10566833
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies
消除淋巴恶性肿瘤 B 细胞受体抑制剂治疗耐药性的新策略
  • 批准号:
    9761500
  • 财政年份:
    2016
  • 资助金额:
    $ 8.43万
  • 项目类别:
Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies
消除淋巴恶性肿瘤 B 细胞受体抑制剂治疗耐药性的新策略
  • 批准号:
    9224740
  • 财政年份:
    2016
  • 资助金额:
    $ 8.43万
  • 项目类别:

相似国自然基金

基于Flow-through流场的双离子嵌入型电容去离子及其动力学调控研究
  • 批准号:
    52009057
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

STEM Advancement through Collaboration in STEM Teacher Preparation
通过 STEM 教师培训合作推动 STEM 进步
  • 批准号:
    2344950
  • 财政年份:
    2024
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Continuing Grant
Conference: RRSP: Responsible Collaboration through Appropriate Research Security
会议:RRSP:通过适当的研究安全进行负责任的合作
  • 批准号:
    2348714
  • 财政年份:
    2024
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Standard Grant
MERGE - Measuring what matters: Improving usability and accessibility of policy frameworks and indicators for multidimensional well-being through collaboration
MERGE - 衡量重要的事情:通过协作提高多维福祉政策框架和指标的可用性和可及性
  • 批准号:
    10092245
  • 财政年份:
    2024
  • 资助金额:
    $ 8.43万
  • 项目类别:
    EU-Funded
POSE: Phase II: Building open source ecosystems in molecular sciences through collaboration and technology
POSE:第二阶段:通过协作和技术构建分子科学领域的开源生态系统
  • 批准号:
    2303740
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Standard Grant
Establishment of a rapid diagnostic method for drug-resistant bacteria in leprosy through international collaboration with Indonesia
与印度尼西亚国际合作建立麻风耐药菌快速诊断方法
  • 批准号:
    23KK0152
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Practices of "Period for Inquiry-Based Cross-Disciplinary Study" through collaboration between zoos and high schools.
动物园与高中合作开展“探究式跨学科学习期”的实践。
  • 批准号:
    23K02426
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A comparative study of moral education through the collaboration of moral subjects and other ubjects in Japan and France : An analysis of teaching materials
日法德育主体与其他主体合作的德育比较研究:教材分析
  • 批准号:
    23K12782
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
  • 批准号:
    10683644
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
Acceleration of risk gene discovery for Tic Disorders through large-scale collaboration
通过大规模合作加速抽动症风险基因的发现
  • 批准号:
    10726443
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
Research on professional development of teacher educators through collaboration between attached school teachers and undergraduate teachers.
附属学校教师与本科教师合作的教师教育工作者专业发展研究
  • 批准号:
    23K02128
  • 财政年份:
    2023
  • 资助金额:
    $ 8.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了